Quantum-Si Incorporated

QSI
Precision medicineBiotech & pharmaceuticalsHealthcare diagnostics
$0.78vs prev close-0.05(-6.32%)
$0.6952W Range$3.10
4% from low
+0.06 (+7.79%)Past 1M
Price
ARK Trade PatternPREMIUM
1M Trades
-
No trades in 1M
1M net buy
$0
0 shares
Portfolio Weight
0.04%
1M -0.01%p
Holding ETFs
1 ETFs
ARKG

Sell · Weight Down

ARK net-sold the stock and the price fell, decreasing its portfolio weight.

Shares -0.6% · Market value -21.0% · Weight -0.01%p

Trade Intensity
No trades in 1M
Trade Log
DateActionETFSharesCloseEst. total
25.10.20SELLARKG86,849$2.59$224.5K
25.10.17SELLARKG137,588$2.28$313.7K
25.10.16SELLARKG498,068$2.54$1.3M
25.01.03SELLARKG452,570$4.29$1.9M
24.12.27SELLARKG1,470,517$3.60$5.3M
23.08.08BUYARKG20,263$2.05$41.5K
23.08.07BUYARKG48,086$2.30$110.6K
23.07.13BUYARKG1,434,997$2.58$3.7M
23.07.12BUYARKG20,742$2.37$49.2K
23.07.07BUYARKG499$2.05$1.0K
23.07.06BUYARKG86,583$1.97$170.6K
23.07.05BUYARKG5,946$2.02$12.0K
23.07.03BUYARKG61,088$1.79$109.3K
23.06.30BUYARKG19,011$1.79$34.0K
23.06.29BUYARKG34,547$1.71$59.1K
10.20SELL
86,849
ARKGClose$2.59Est. total$224.5K
10.17SELL
137,588
ARKGClose$2.28Est. total$313.7K
10.16SELL
498,068
ARKGClose$2.54Est. total$1.3M
01.03SELL
452,570
ARKGClose$4.29Est. total$1.9M
12.27SELL
1,470,517
ARKGClose$3.60Est. total$5.3M
08.08BUY
20,263
ARKGClose$2.05Est. total$41.5K
08.07BUY
48,086
ARKGClose$2.30Est. total$110.6K
07.13BUY
1,434,997
ARKGClose$2.58Est. total$3.7M
07.12BUY
20,742
ARKGClose$2.37Est. total$49.2K
07.07BUY
499
ARKGClose$2.05Est. total$1.0K
07.06BUY
86,583
ARKGClose$1.97Est. total$170.6K
07.05BUY
5,946
ARKGClose$2.02Est. total$12.0K
07.03BUY
61,088
ARKGClose$1.79Est. total$109.3K
06.30BUY
19,011
ARKGClose$1.79Est. total$34.0K
06.29BUY
34,547
ARKGClose$1.71Est. total$59.1K
1 / 2

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline
Institutional Holders
1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest
LIVE
Shares
6,744,049
Portfolio Weight
0.04%
in ETF 0.31%
Est. Value
$5M
30D Net
$0

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Analyst recommendation distribution3
Overall Opinion
Buy
Buy
2
Hold
1
Analyst Targets
avg.
$2.30
vs Current +177.1% upside
Current$0.83
Low ~ High$1.00 ~ $4.00
Firm
Position
Price Target
Upside / Downside
Close Price
Action
Date
Canaccord Genuity
Hold
$1.00
+20.48%
Maintain
2026-03-05
Canaccord Genuity
Hold
$1.50
+80.72%
Maintain
2025-12-22
Canaccord Genuity
Hold
$2.00
+140.96%
Maintain
2025-10-27
Canaccord Genuity
Hold
$1.00
+20.48%
Maintain
2025-09-09
HC Wainwright & Co.
Buy
N/A
N/A
Maintain
2025-05-19
1 / 3
Avg Target
$2.30
vs Current +177.1% upside
Buy
3 analysts
Buy 2Hold 1
Low $1.00
Current $0.83
High $4.00
FirmPositionTargetUpsideCloseActionDate
Canaccord GenuityHold$1.00+20.48%Maintain26.03.05
Canaccord GenuityHold$1.50+80.72%Maintain25.12.22
Canaccord GenuityHold$2.00+140.96%Maintain25.10.27
Canaccord GenuityHold$1.00+20.48%Maintain25.09.09
HC Wainwright & Co.BuyN/AN/AMaintain25.05.19
1 / 3

Price Information

Previous Close$0.78
Open$0.79
Day Range$0.78 - $0.93
52-Week Range$0.69 - $3.10
1-Year Change-26.75%

Trading Volume

Volume7,551,496
Avg Volume (3mo)4,560,111

Valuation

Market Cap182.8M
Book Value$0.82
Shares Outstanding198,946,412

Financials

Revenue (TTM)1.6M
Net Income-98,519,000
EPS$-0.46
EBITDA-87,360,000

Profitability

P/E Ratio-
P/B Ratio1.01
Return on Equity (ROE)-49.11%
Return on Assets (ROA)-25.71%
Profit Margin0.00%
EV/EBITDA-0.85
Beta3.25

Dividend

Dividend Rate-
Dividend Yield-

Technical

RSI(14)61.62
Company Overview

Quantum-Si Incorporated is a life sciences company developing a single-molecule detection platform for Next Generation Protein Sequencing (NGPS). Their main products include the Platinum and Platinum Pro NGPS instruments, along with library, barcoding, and sequencing kits, and analysis software. These offerings aim to provide researchers with accessible, high-resolution protein analysis for various applications.

P/B
1.01
Price-to-Book
ROE
-49.1%
Persistent loss
Beta
3.25
Extreme volatility
RSI(14)
61.6
Neutral zone

AI-generated summary. Not investment advice.

Recent News

Mymoneywood cross-analyzes and curates publicly available SEC 13F-HR filing data. We do not provide investment advice and do not recommend buying or selling any specific securities.

Past performance does not guarantee future results. All investment decisions and responsibilities rest with the user.

Terms of Service·Investment Disclaimer·Privacy Policy·Refund Policy

Always summer | biz@mymoneywood.com
© 2026 Always summer. All rights reserved.

Enter your email below to sign up for the newsletter.

By entering your email you agree to our Privacy Policy. You can unsubscribe anytime.